
Kapicef S 500mg/250mg Injection
Marketer
Godrams Lifeline
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Kapicef S 500mg/250mg Injection
Cefixime and Sulbactam injection (500mg/250mg), marketed as Kapicef S, combats various bacterial infections by inhibiting microbial growth and spread. Administration must be under a doctor's guidance; complete the prescribed course regardless of symptom improvement to ensure efficacy. Missed doses should be avoided. Potential side effects include nausea, vomiting, diarrhea, and indigestion. Severe side effects or allergic reactions (rash, itching, swelling, breathing difficulties) require immediate medical attention. Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. This is particularly crucial for pregnant or breastfeeding individuals. Alcohol should be avoided due to potential increased drowsiness. While it generally doesn't affect driving ability, avoid operating vehicles if drowsiness or dizziness occur. Adequate rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Your doctor may order tests to monitor the medicine's effects.
Primary Ingredients of Kapicef S 500mg/250mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Kapicef S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Kapicef S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Kapicef S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Kapicef S 500mg/250mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Kapicef S 500mg/250mg Injection works:
The injectable formulation Kapicef S, containing 500mg Ceftriaxone and 250mg Sulbactam, employs a dual-drug mechanism. Ceftriaxone, a third-generation cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Sulbactam, a beta-lactamase inhibitor, complements Ceftriaxone by countering bacterial resistance mechanisms, thus boosting its antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Kapicef S 500mg/250mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Kapicef S (500mg/250mg) is typically deemed safe for use during pregnancy. Preclinical trials using animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Kapicef S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Kapicef S 500mg/250mg Injection may induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Kapicef S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication, Kapicef S 500mg/250mg, requires careful administration in individuals with significant hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. Altering the dosage of Kapicef S 500mg/250mg Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Kapicef S 500mg/250mg Injection :
Omit a scheduled Kapicef S 500mg/250mg Injection? Seek medical advice.
Facts to Know About Kapicef S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
